Scientists in China are about to become the first to use the game-changing gene-editing technology Crispr-Cas9 on humans. CRISPR allows scientists to easily add in or delete small bits of DNA in order ...
Morning Overview on MSN
Programmable CRISPR cuts stem cell timing from months to weeks
Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...
Two studies published in Nature Medicine June 11 contribute to a small body of literature suggesting cells edited with CRISPR-Cas9 may cause cancer. Here are five things to know about the studies and ...
Broad Institute of MIT and Harvard and the McGovern Institute for Brain Research have developed a way to significantly cut down on “off-target” editing errors when using CRISPR Share on Facebook ...
Morning Overview on MSNOpinion
How genetic engineering could reshape medicine and human life
Genetic engineering is moving from the lab bench into clinics, farms, and even family planning decisions, promising to change ...
Megan Molteni reports on discoveries from the frontiers of genomic medicine, neuroscience, and reproductive tech. She joined STAT in 2021 after covering health and science at WIRED. You can reach ...
"Eugenics seeks to improve by eliminating the characteristics considered at a particular time and place to be disadvantages and to maximize those considered normal." When you purchase through links on ...
The Influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to 100 million deaths globally. In the U.S. alone, it is estimated that, despite seasonally updated ...
Like the find-and-replace feature of a word processor, CRISPR-based engineering allows scientists to quickly and efficiently edit DNA sequences with base pair precision. Lauded as the great ...
The first human trial of cells that have been tweaked by the genome-editing technique CRISPR will begin in China in August, Nature reports. The group will take white blood cells, which are part of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results